KEY STEP. “Last year, bioengineer Daniel Anderson of the Massachusetts Institute of Technology in Cambridge and his colleagues used CRISPR in mice to correct a mutation associated with a human metabolic disease called tyrosinaemia. It was the first use of CRISPR to fix a disease-causing mutation in an adult animal — and an important step towards using the technology for gene therapy in humans.”
http://www.nature.com/news/crispr-the-disruptor-1.17673
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022